Literature DB >> 18045928

Activity-dependent ubiquitination of GABA(A) receptors regulates their accumulation at synaptic sites.

Richard S Saliba1, Guido Michels, Tija C Jacob, Menelas N Pangalos, Stephen J Moss.   

Abstract

GABA(A) receptors (GABA(A)Rs) are the major mediators of fast synaptic inhibition in the brain. In neurons, these receptors undergo significant rates of endocytosis and exocytosis, processes that regulate both their accumulation at synaptic sites and the efficacy of synaptic inhibition. Here we have evaluated the role that neuronal activity plays in regulating the residence time of GABA(A)Rs on the plasma membrane and their targeting to synapses. Chronic blockade of neuronal activity dramatically increases the level of the GABA(A)R ubiquitination, decreasing their cell surface stability via a mechanism dependent on the activity of the proteasome. Coincident with this loss of cell surface expression levels, TTX treatment reduced both the amplitude and frequency of miniature inhibitory synaptic currents. Conversely, increasing the level of neuronal activity decreases GABA(A)R ubiquitination enhancing their stability on the plasma membrane. Activity-dependent ubiquitination primarily acts to reduce GABA(A)R stability within the endoplasmic reticulum and, thereby, their insertion into the plasma membrane and subsequent accumulation at synaptic sites. Thus, activity-dependent ubiquitination of GABA(A)Rs and their subsequent proteasomal degradation may represent a potent mechanism to regulate the efficacy of synaptic inhibition and may also contribute to homeostatic synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045928      PMCID: PMC6673389          DOI: 10.1523/JNEUROSCI.3277-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  72 in total

1.  Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14.

Authors:  Bula J Bhattacharyya; Scott M Wilson; Hosung Jung; Richard J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-09       Impact factor: 4.249

Review 2.  The ubiquitin-proteasome pathway and synaptic plasticity.

Authors:  Ashok N Hegde
Journal:  Learn Mem       Date:  2010-06-21       Impact factor: 2.460

3.  Activity-dependent regulation of inhibition via GAD67.

Authors:  C Geoffrey Lau; Venkatesh N Murthy
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

4.  Activity-dependent phosphorylation of GABAA receptors regulates receptor insertion and tonic current.

Authors:  Richard S Saliba; Karla Kretschmannova; Stephen J Moss
Journal:  EMBO J       Date:  2012-04-24       Impact factor: 11.598

Review 5.  Roles of ubiquitination at the synapse.

Authors:  Kevin F Haas; Kendal Broadie
Journal:  Biochim Biophys Acta       Date:  2008-01-05

Review 6.  Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond.

Authors:  Z Josh Huang
Journal:  J Physiol       Date:  2009-02-02       Impact factor: 5.182

Review 7.  GABAA receptor-mediated tonic depolarization in developing neural circuits.

Authors:  Juu-Chin Lu; Yu-Tien Hsiao; Chung-Wei Chiang; Chih-Tien Wang
Journal:  Mol Neurobiol       Date:  2013-09-11       Impact factor: 5.590

8.  Clptm1 Limits Forward Trafficking of GABAA Receptors to Scale Inhibitory Synaptic Strength.

Authors:  Yuan Ge; Yunhee Kang; Robert M Cassidy; Kyung-Mee Moon; Renate Lewis; Rachel O L Wong; Leonard J Foster; Ann Marie Craig
Journal:  Neuron       Date:  2018-01-25       Impact factor: 17.173

9.  Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibition.

Authors:  Tija C Jacob; Guido Michels; Liliya Silayeva; Julia Haydon; Francesca Succol; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

Review 10.  The role of the ubiquitin proteasome system in ischemia and ischemic tolerance.

Authors:  Robert Meller
Journal:  Neuroscientist       Date:  2009-01-30       Impact factor: 7.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.